不同国家的COVID-19大流行:俄罗斯、巴西和印度

Samantha Dos Santos Rocha Ferreira, KYu Koreshkova, Y. Guduru, LS Rocha, L. Perminova
{"title":"不同国家的COVID-19大流行:俄罗斯、巴西和印度","authors":"Samantha Dos Santos Rocha Ferreira, KYu Koreshkova, Y. Guduru, LS Rocha, L. Perminova","doi":"10.24075/rbh.2022.044","DOIUrl":null,"url":null,"abstract":"At the end of December 2019, cases of pneumonia of unknown etiology were registered in China. The cause represented by the novel coronavirus SARS-CoV-2 was established later. The infection has spread rapidly around the world. According to the latest official data, over 531,959,093 cases of the infection and over 6,299,068 confirmed COVID-19-related mortality cases were reported in 215 countries. The study aimed to examine characteristic features of the novel coronavirus pandemic in Russia, Brazil, and India from April 2020 to March 2022. Official statistical data on COVID-19-related morbidity, mortality, and vaccination from the websites of the Russian Federal State Agency for Health and Consumer Rights and Johns Hopkins Institute were collected for every country from April 01, 2020, to March 01, 2022. Out of the three examined countries, the highest incidence and mortality for COVID-19 per one million people were found in Brazil, followed by Russia and India respectively. The level of vaccination was the highest in Brazil (73%). It was followed by India (53%) and Russia (50%). The Delta variant of the virus was first identified in India in October 2020. In June of the next year, it accounted for the majority of COVID-19 cases registered in three countries. The same was true for the Omicron variant. Despite the efforts taken within the last two years to contain COVID-19 (development of vaccines, use of other antiepidemic agents), the coronavirus infection is still of cyclical patterns along with increased morbidity. Based on the obtained data, massive vaccination effectively reduced mortality due to COVID-19 though many new variants occurred.","PeriodicalId":119609,"journal":{"name":"Российский вестник гигиены","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The COVID-19 pandemic in different countries: Russia, Brazil and India\",\"authors\":\"Samantha Dos Santos Rocha Ferreira, KYu Koreshkova, Y. Guduru, LS Rocha, L. Perminova\",\"doi\":\"10.24075/rbh.2022.044\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"At the end of December 2019, cases of pneumonia of unknown etiology were registered in China. The cause represented by the novel coronavirus SARS-CoV-2 was established later. The infection has spread rapidly around the world. According to the latest official data, over 531,959,093 cases of the infection and over 6,299,068 confirmed COVID-19-related mortality cases were reported in 215 countries. The study aimed to examine characteristic features of the novel coronavirus pandemic in Russia, Brazil, and India from April 2020 to March 2022. Official statistical data on COVID-19-related morbidity, mortality, and vaccination from the websites of the Russian Federal State Agency for Health and Consumer Rights and Johns Hopkins Institute were collected for every country from April 01, 2020, to March 01, 2022. Out of the three examined countries, the highest incidence and mortality for COVID-19 per one million people were found in Brazil, followed by Russia and India respectively. The level of vaccination was the highest in Brazil (73%). It was followed by India (53%) and Russia (50%). The Delta variant of the virus was first identified in India in October 2020. In June of the next year, it accounted for the majority of COVID-19 cases registered in three countries. The same was true for the Omicron variant. Despite the efforts taken within the last two years to contain COVID-19 (development of vaccines, use of other antiepidemic agents), the coronavirus infection is still of cyclical patterns along with increased morbidity. Based on the obtained data, massive vaccination effectively reduced mortality due to COVID-19 though many new variants occurred.\",\"PeriodicalId\":119609,\"journal\":{\"name\":\"Российский вестник гигиены\",\"volume\":\"44 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Российский вестник гигиены\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24075/rbh.2022.044\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Российский вестник гигиены","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24075/rbh.2022.044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

截至2019年12月底,中国登记了不明原因肺炎病例。以新型冠状病毒SARS-CoV-2为代表的病因是后来确立的。这种传染病在全世界迅速蔓延。根据最新官方数据,215个国家报告了超过531,959,093例感染病例和超过6299,068例与covid -19相关的确诊死亡病例。该研究旨在研究2020年4月至2022年3月期间俄罗斯、巴西和印度新型冠状病毒大流行的特征。从2020年4月1日至2022年3月1日,从俄罗斯联邦国家卫生和消费者权利机构和约翰霍普金斯研究所的网站上收集了每个国家与covid -19相关的发病率、死亡率和疫苗接种的官方统计数据。在被调查的三个国家中,巴西的新冠肺炎每百万人的发病率和死亡率最高,其次是俄罗斯和印度。巴西的疫苗接种水平最高(73%)。紧随其后的是印度(53%)和俄罗斯(50%)。该病毒的Delta变体于2020年10月首次在印度被发现。第二年6月,在三个国家登记的COVID-19病例中,它占了大多数。欧米克隆变异也是如此。尽管在过去两年中为控制COVID-19做出了努力(开发疫苗,使用其他抗流行病药物),但冠状病毒感染仍然具有周期性,发病率也在增加。根据获得的数据,尽管出现了许多新的变异,但大规模疫苗接种有效地降低了COVID-19的死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The COVID-19 pandemic in different countries: Russia, Brazil and India
At the end of December 2019, cases of pneumonia of unknown etiology were registered in China. The cause represented by the novel coronavirus SARS-CoV-2 was established later. The infection has spread rapidly around the world. According to the latest official data, over 531,959,093 cases of the infection and over 6,299,068 confirmed COVID-19-related mortality cases were reported in 215 countries. The study aimed to examine characteristic features of the novel coronavirus pandemic in Russia, Brazil, and India from April 2020 to March 2022. Official statistical data on COVID-19-related morbidity, mortality, and vaccination from the websites of the Russian Federal State Agency for Health and Consumer Rights and Johns Hopkins Institute were collected for every country from April 01, 2020, to March 01, 2022. Out of the three examined countries, the highest incidence and mortality for COVID-19 per one million people were found in Brazil, followed by Russia and India respectively. The level of vaccination was the highest in Brazil (73%). It was followed by India (53%) and Russia (50%). The Delta variant of the virus was first identified in India in October 2020. In June of the next year, it accounted for the majority of COVID-19 cases registered in three countries. The same was true for the Omicron variant. Despite the efforts taken within the last two years to contain COVID-19 (development of vaccines, use of other antiepidemic agents), the coronavirus infection is still of cyclical patterns along with increased morbidity. Based on the obtained data, massive vaccination effectively reduced mortality due to COVID-19 though many new variants occurred.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
相关文献
二甲双胍通过HDAC6和FoxO3a转录调控肌肉生长抑制素诱导肌肉萎缩
IF 8.9 1区 医学Journal of Cachexia, Sarcopenia and MusclePub Date : 2021-11-02 DOI: 10.1002/jcsm.12833
Min Ju Kang, Ji Wook Moon, Jung Ok Lee, Ji Hae Kim, Eun Jeong Jung, Su Jin Kim, Joo Yeon Oh, Sang Woo Wu, Pu Reum Lee, Sun Hwa Park, Hyeon Soo Kim
具有疾病敏感单倍型的非亲属供体脐带血移植后的1型糖尿病
IF 3.2 3区 医学Journal of Diabetes InvestigationPub Date : 2022-11-02 DOI: 10.1111/jdi.13939
Kensuke Matsumoto, Taisuke Matsuyama, Ritsu Sumiyoshi, Matsuo Takuji, Tadashi Yamamoto, Ryosuke Shirasaki, Haruko Tashiro
封面:蛋白质组学分析确定IRSp53和fastin是PRV输出和直接细胞-细胞传播的关键
IF 3.4 4区 生物学ProteomicsPub Date : 2019-12-02 DOI: 10.1002/pmic.201970201
Fei-Long Yu, Huan Miao, Jinjin Xia, Fan Jia, Huadong Wang, Fuqiang Xu, Lin Guo
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Psychophysiological features of students at different risk of internet-addictive behavior Specialty "preventive medicine": from applicant to specialist Hygienic characteristics of some aspects of students’ psychological health Pressing issues of medical assistance of students receiving secondary medical education Hygienic assessment of daily dietary intake of medical students
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1